Newsroom

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/13/2026 Issue ¦ GE Capital European Funding - Series 4661 EUR 50,000,000 FRN Due 15 Oct 2032     ISIN Number ¦ XS0322844779 ISIN Reference ¦ 32284477 Issue Nomin EUR ¦ 50000000 Period ¦ 1/15/2026 to 4/15/2026   Payment Date 4/15/2026 Number of Days ¦ 90 Rate ¦ 2.566   Denomination EUR ¦ 50000   ¦ 50000000   ¦       Amount Payable per Denomination ¦ 320.75   ¦ 320750   ¦       Bank of New York    ...

LONDON--(BUSINESS WIRE)--  Oberon AIM VCT Net Asset Value (s) As at the close on the 31ST December 2025 and based on mid market prices, the net asset value of the Oberon AIM VCT was 27.54p per share....

GREAT FALLS, Mont.--(BUSINESS WIRE)--For a second consecutive year, Kovacich Snipes Johnson partners Mark Kovacich and Ben Snipes are the only Montana-based lawyers included in the Lawdragon 500 Leading Lawyers in America legal guide. Mr. Kovacich and Mr. Snipes are both recognized for excellence in plaintiff personal injury/mass torts litigation in the 2026 edition. Dominated by major market attorneys, the list nonetheless takes note of the work done by attorneys nationwide “who inspire us and...

LYON, France--(BUSINESS WIRE)--Fabentech, société biopharmaceutique française spécialisée dans les contre-mesures médicales de lutte contre les menaces biologiques, annonce aujourd'hui avoir obtenu l'autorisation de mise sur le marché de Ricimed®, un traitement contre l'intoxication à la ricine. Ricimed®, un antidote contre l'une des substances naturelles les plus toxiques au monde En complément des soins de soutien, et dans les conditions graves nécessitant une administration immédiate, Ricime...

LYON, Frankrijk--(BUSINESS WIRE)--Fabentech, een Frans biofarmaceutisch bedrijf gespecialiseerd in medische tegenmaatregelen tegen biologische bedreigingen, maakte vandaag bekend dat het bedrijf een vergunning werd verleend om Ricimed® op de markt te brengen, een behandeling tegen ricinevergiftiging. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is...

OAK BROOK, Ill.--(BUSINESS WIRE)--Inland announced that Matthew Fries will serve as CEO and President of Inland Real Estate Investment Corporation (“Inland Investments”)....

NEW YORK & CHICAGO--(BUSINESS WIRE)--Capital Engine®, a global FinTech and investment bank building mission-critical infrastructure for the estimated $65 trillion private markets, today announced a strategic alliance with Regiment Securities, LLC (Regiment), a FINRA-registered financial services firm, to expand private-market distribution, co-syndication capabilities, and marketplace connectivity. The alliance is designed to enable the co-syndication of select private investment opportunities a...

PLEASANTON, Calif.--(BUSINESS WIRE)--Blackhawk Network expands partnership with Mastercard to launch two new filtered prepaid card rewards products....

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has been selected as one of 10 companies awarded contracts under the Defense Microelectronics Activity’s (DMEA) Advanced Technology Support Program V (ATSP V). The 10-year, government-wide, multiple award Indefinite Delivery/Indefinite Delivery (IDIQ) contract vehicle has a ceiling of $25.35 billion, to rapidly provide engineering solutions for electronics and software problems. Under the contract, Battelle will deliver engineering development capabilit...

LEXINGTON, Massachusetts--(BUSINESS WIRE)--Agenus Inc. (Nasdaq : AGEN), chef de file de l’innovation en immuno-oncologie, annonce aujourd’hui que l’Agence nationale de sécurité du médicament et des produits de santé (ANSM) a approuvé un protocole de traitement national actualisé pour le botensilimab (BOT) plus le balstilimab (BAL) dans le cadre de l’autorisation d’accès compassionnel (AAC) en France. Le protocole mis à jour étend l’autorisation précédemment accordée par la France en matière d'A...